Alcohol, the vagus nerve and multi-organ inflammation
Alcohol, the vagus nerve and multi-organ inflammation
批准号:
8334496
负责人:
JOHN M. LITTLETON
金额:
$19.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-20 至 2014-08-31
关键词:
AcetylcholineAcuteAffectAffinityAgonistAlcohol-Induced DisordersAlcoholismAlcoholsAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsBrainCell physiologyCellsCholineChronicConsumptionDependenceDevelopmentDrug EvaluationEndotoxinsExploratory/Developmental GrantHeart RateIn VitroInflammationInflammation MediatorsInflammatoryInflammatory ResponseKnock-outKnockout MiceLibrariesLigandsLipopolysaccharidesLiverLungMediator of activation proteinMedicalMethodsMusNerveNeuropathyNicotinic ReceptorsOrganOxidative StressPeritoneal MacrophagesPharmaceutical PreparationsPhysiologicalPlant ExtractsPopulationProcessPropertyRoleScreening procedureSumTelemetryTestingTherapeuticTissuesVagus nerve structureVariantWild Type Mousealcohol abuse therapyalcohol effectalcohol exposurealcohol researchalcoholism therapyalpha-bungarotoxin receptorbasecell typecholinergiccostdrug discoveryin vivomacrophageneuronal cell bodyneuroprotectionnovelnovel therapeutic interventionpreventreceptorresearch studyresponserestrainttherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The tenth cranial nerve, the vagus, is distributed throughout the body, including major divisions to all parts of the gut, and to the liver. This cholinergic nerve restrains inflammation, in all the organs to which the vagus is distributed, by the tonic release of acetylcholine (ACh) onto nicotinic receptors (nicAChRs) of the alpha7- subtype. In addition to their presence on inflammatory cells, alpha7-nicAChRs are also present on cell bodies of the vagus in the CNS, where they cause vagal activation and neuroprotection. Since the presence of alcohol inhibits alpha7-nicAChRs, and a known chronic effect is to cause vagal neuropathy, these anti-inflammatory effects of the vagus are seriously compromised during alcohol exposure. The primary hypothesis is that this reduced vagal function contributes to the chronic inflammation following oxidative stress, which is a common feature of alcohol-induced damage in many organs. If correct, this predicts that compounds with alpha7- nicAChR agonist properties will protect against alcohol-induced tissue damage, particularly if these compounds are also anti-oxidants. The first specific aim of this proposal is to test the primary hypothesis in vitro by studying the interactions of alcohol and alpha7-nicAChR ligands on endotoxin-induced release of mediators from inflammatory cells (splenic, lung and peritoneal macrophages) from wild-type, and alpha7-nicAChR knock-out, C57Bl/6J mice. The second specific aim is to test the hypothesis in vivo by exposing C57Bl/6J mice (wild-type, vagotomized, and alpha7-nicAChR knockouts) chronically to alcohol by forced consumption, and then evaluating endotoxin-induced release of inflammatory mediators in vivo. As part of these studies we will evaluate the therapeutic potential of the alpha7-nicAChR agonist, choline, and a methylquercetagetin which acts as a partial agonist at alpha7-nicAChRs. The latter was recently discovered by screening a native plant extract library, and has potent anti-oxidant activity in addition to its action at nicAChRs, where it has an affinity comparable to choline. The ability of these compounds to inhibit endotoxin-induced release of inflammatory mediators following alcohol exposure will be studied in vitro and in vivo using the same methods as above. This project therefore tests a novel hypothesis for alcohol-induced organ damage based on the interaction between brain, gut and liver as represented by the vagus nerve, and tests a novel therapeutic approach to this.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads
-
批准号:10267035
-
项目类别:
-
资助金额:$61.75万
-
财政年份:2018
-
负责人:JOHN M. LITTLETON
-
依托单位:
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads
-
批准号:10078986
-
项目类别:
-
资助金额:$62.4万
-
财政年份:2018
-
负责人:JOHN M. LITTLETON
-
依托单位:
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
-
批准号:10459072
-
项目类别:
-
资助金额:$101.67万
-
财政年份:2017
-
负责人:JOHN M. LITTLETON
-
依托单位:
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
-
批准号:9397465
-
项目类别:
-
资助金额:$67.25万
-
财政年份:2017
-
负责人:JOHN M. LITTLETON
-
依托单位:
Mutant transgenic plant cells as a novel source of drugs
-
批准号:9253077
-
项目类别:
-
资助金额:$45.58万
-
财政年份:2016
-
负责人:JOHN M. LITTLETON
-
依托单位:
Mutant transgenic plant cells as a novel source of drugs
-
批准号:9356446
-
项目类别:
-
资助金额:$48.96万
-
财政年份:2016
-
负责人:JOHN M. LITTLETON
-
依托单位:
Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles
-
批准号:9343261
-
项目类别:
-
资助金额:$53.03万
-
财政年份:2014
-
负责人:JOHN M. LITTLETON
-
依托单位:
Harvesting specific plant metabolites from hairy root cultures using magnetized n
-
批准号:8712853
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2014
-
负责人:JOHN M. LITTLETON
-
依托单位:
Novel flavonoids as anti-inflammatory agents in alcoholism
-
批准号:8251289
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2014
-
负责人:JOHN M. LITTLETON
-
依托单位:
Alcohol, the vagus nerve and multi-organ inflammation
-
批准号:8064072
-
项目类别:
-
资助金额:$16.51万
-
财政年份:2011
-
负责人:JOHN M. LITTLETON
-
依托单位:
Selection-driven plant metabolites for treatment of CNS diseases
-
批准号:8731785
-
项目类别:
-
资助金额:$48.76万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Selection-driven plant metabolites for treatment of CNS diseases
-
批准号:8905682
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Novel estrogen receptor ligands from plant genomics
-
批准号:7999504
-
项目类别:
-
资助金额:$13.86万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Novel estrogen receptor ligands from plant genomics
-
批准号:8310769
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Selection-driven plant metabolites for treatment of CNS diseases
-
批准号:8141663
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Selection-driven plant metabolites for treatment of CNS diseases
-
批准号:7999448
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Selection-driven plant metabolites for treatment of CNS diseases
-
批准号:8131585
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Novel estrogen receptor ligands from plant genomics
-
批准号:8487647
-
项目类别:
-
资助金额:$2.89万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Selection-driven plant metabolites for treatment of CNS diseases
-
批准号:8589434
-
项目类别:
-
资助金额:$51.67万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
Novel estrogen receptor ligands from plant genomics
-
批准号:8136646
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2010
-
负责人:JOHN M. LITTLETON
-
依托单位:
海外基金